FDA Inspection 1078119 — J K Cancer Institute
The FDA completed an inspection of J K Cancer Institute on Jan 17, 2019 in Kanpur. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 17, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Kanpur (India)
Additional Details
Clinical BA/BE